| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Medicine and Clinical Science (H.A., K.N.), Kyoto University Graduate School of Medicine, and Translational Research Center (K.T., H.I., H.H., T.A., K.K.), Kyoto University Hospital, Kyoto 606-8507; and Departments of Bioscience (Y.A.) and Biochemistry (K.K.), National Cardiovascular Center Research Institute, Osaka 565-8565, Japan
Address all correspondence and requests for reprints to: Kazuhiko Takaya, M.D., Ph.D., Translational Research Center, Kyoto University Hospital, Kyoto 606-8507, Japan. E-mail: ktakaya{at}kuhp.kyoto-u.ac.jp.
Ghrelin, a 28-amino acid acylated peptide, displays strong GH-releasing activity in concert with GHRH. The fatty acid modification of ghrelin is essential for the actions, and des-acyl ghrelin, which lacks the modification, has been assumed to be devoid of biological effects. Some recent reports, however, indicate that des-acyl ghrelin has effects on cell proliferation and survival. In the present study, we generated two lines of transgenic mice bearing the preproghrelin gene under the control of chicken ß-actin promoter. Transgenic mice overexpressed des-acyl ghrelin in a wide variety of tissues, and plasma des-acyl ghrelin levels reached 10- and 44-fold of those in control mice. They exhibited lower body weights and shorter nose-to-anus lengths, compared with control mice. The serum GH levels tended to be lower, and the serum IGF-I levels were significantly lower in both male and female transgenic mice than control mice. The responses of GH to administered GHRH were normal, whereas those to administered ghrelin were reduced, especially in female transgenic mice, compared with control mice. These data suggest that overexpressed des-acyl ghrelin may modulate the GH-IGF-I axis and result in small phenotype in transgenic mice.
This article has been cited by other articles:
 |
|
 |
|
  J. S. Davies, P. Kotokorpi, S. R. Eccles, S. K. Barnes, P. F. Tokarczuk, S. K. Allen, H. S. Whitworth, I. A. Guschina, B. A. J. Evans, A. Mode, et al. Ghrelin Induces Abdominal Obesity Via GHS-R-Dependent Lipid Retention Mol. Endocrinol., June 1, 2009; 23(6): 914 - 924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Li, J. He, W. Hu, and Z. Yin The Essential Role of Endogenous Ghrelin in Growth Hormone Expression during Zebrafish Adenohypophysis Development Endocrinology, June 1, 2009; 150(6): 2767 - 2774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Bewick, A. Kent, D. Campbell, M. Patterson, M. A. Ghatei, S. R. Bloom, and J. V. Gardiner Mice With Hyperghrelinemia Are Hyperphagic and Glucose Intolerant and Have Reduced Leptin Sensitivity Diabetes, April 1, 2009; 58(4): 840 - 846. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Zhang, B. Chai, J.-y. Li, H. Wang, and M. W. Mulholland Effect of Des-acyl Ghrelin on Adiposity and Glucose Metabolism Endocrinology, September 1, 2008; 149(9): 4710 - 4716. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Reed, S. C. Benoit, P. T. Pfluger, M. H. Tschop, D. A. D'Alessio, and R. J. Seeley Mice with chronically increased circulating ghrelin develop age-related glucose intolerance Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E752 - E760. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rauh, M. Groschl, and W. Rascher Simultaneous Quantification of Ghrelin and Desacyl-Ghrelin by Liquid Chromatography-Tandem Mass Spectrometry in Plasma, Serum, and Cell Supernatants Clin. Chem., May 1, 2007; 53(5): 902 - 910. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhu, Y. Cao, K. Voodg, and D. F. Steiner On the Processing of Proghrelin to Ghrelin J. Biol. Chem., December 15, 2006; 281(50): 38867 - 38870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Nonogaki, K. Nozue, and Y. Oka Hyperphagia Alters Expression of Hypothalamic 5-HT2C and 5-HT1B Receptor Genes and Plasma Des-Acyl Ghrelin Levels in Ay Mice Endocrinology, December 1, 2006; 147(12): 5893 - 5900. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Zigman and J. K. Elmquist In search of an effective obesity treatment: A shot in the dark or a shot in the arm? PNAS, August 29, 2006; 103(35): 12961 - 12962. [Full Text] [PDF]
|
|
|
|
|
|
A. C. Martini, R. Fernandez-Fernandez, S. Tovar, V. M. Navarro, E. Vigo, M. J. Vazquez, J. S. Davies, N. M. Thompson, E. Aguilar, L. Pinilla, et al. Comparative Analysis of the Effects of Ghrelin and Unacylated Ghrelin on Luteinizing Hormone Secretion in Male Rats Endocrinology, May 1, 2006; 147(5): 2374 - 2382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Wei, X. Qi, J. Reed, J. Ceci, H.-Q. Wang, G. Wang, E. W. Englander, and G. H. Greeley Jr. Effect of chronic hyperghrelinemia on ingestive action of ghrelin Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R803 - R808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P L Jeffery, R E Murray, A H Yeh, J F McNamara, R P Duncan, G D Francis, A C Herington, and L K Chopin Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines Endocr. Relat. Cancer, December 1, 2005; 12(4): 839 - 850. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. V. Zhang, P.-G. Ren, O. Avsian-Kretchmer, C.-W. Luo, R. Rauch, C. Klein, and A. J. W. Hsueh Obestatin, a Peptide Encoded by the Ghrelin Gene, Opposes Ghrelin's Effects on Food Intake Science, November 11, 2005; 310(5750): 996 - 999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Iwakura, K. Hosoda, C. Son, J. Fujikura, T. Tomita, M. Noguchi, H. Ariyasu, K. Takaya, H. Masuzaki, Y. Ogawa, et al. Analysis of Rat Insulin II Promoter-Ghrelin Transgenic Mice and Rat Glucagon Promoter-Ghrelin Transgenic Mice J. Biol. Chem., April 15, 2005; 280(15): 15247 - 15256. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
